Home › Funds › Knoll Capital Management, LLC › OCUL

Knoll Capital Management, LLC position in OCUL

OCULAR THERAPEUTIX INC · Health Care

Knoll Capital Management, LLC reported holding 1,150,400 shares of OCUL (OCULAR THERAPEUTIX INC) in its Q2 2026 13F filing — a position valued at US$11.3M, representing 5.27% of its reported portfolio and ranking #5 among its reported holdings. Knoll Capital Management, LLC has disclosed OCUL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.15M sh
Reported value held$11.30M
Portfolio Weight5.27%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Knoll Capital Management, LLC's OCUL position evolved

Knoll Capital Management, LLC first disclosed a stake in OCUL in Q3 2023 at 400 shares (US$1K). The position peaked in Q2 2026 at 1,150,400 shares, worth US$11.3M. Across 12 filings, Knoll Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 1,150,400 shares valued at US$11.3M — an increase of 550,000 shares quarter over quarter.. Notable position changes include a 50000% increase in Q4 2023 (shares rose 104% over the following quarter), a 200% increase in Q3 2024 (shares fell 2% over the following quarter), a 92% increase in Q2 2026 (shares fell 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 400 $1.26K New
Q4 2023 200.40K $893.78K Add
Q1 2024 200.40K $1.82M Hold
Q2 2024 200.40K $1.37M Hold
Q3 2024 600.40K $5.22M Add
Q4 2024 600.40K $5.13M Hold
Q1 2025 600.40K $4.40M Hold
Q2 2025 600.40K $1.86M Hold
Q3 2025 600.40K $7.02M Hold
Q4 2025 600.40K $7.28M Hold
Q1 2026 600.40K $5.09M Hold
Q2 2026 1.15M $11.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCUL and 13F data

OCUL (OCULAR THERAPEUTIX INC) is a Health Care company. 42 other funds we track also report a position in OCUL — the largest reported positions include Deep Track Capital, LP (US$193.3M), Avoro Capital Advisors LLC (US$123.1M), SUMMER ROAD LLC (US$119.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCUL

All OCUL fund holders →

FAQ

How long has Knoll Capital Management, LLC held OCUL?

Knoll Capital Management, LLC has disclosed OCUL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Knoll Capital Management, LLC's current position in OCUL?

As of Q2 2026, Knoll Capital Management, LLC holds 1.15M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $11.30M, representing 5.27% of its reported portfolio and ranking #5.

Has Knoll Capital Management, LLC been buying or selling OCUL?

In the latest 13F filing (Q2 2026), Knoll Capital Management, LLC increased its position in OCUL. The position peaked in Q2 2026 at 1.15M shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Deep Track Capital, LP, Avoro Capital Advisors LLC, SUMMER ROAD LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.